Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 14Breast Neoplasms 12Multiple Myeloma 8Neoplasm Metastasis 5Pain 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Renal Insufficiency 1Pleural Effusion, Malignant 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Neoplastic Cells, Circulating 1Lung Neoplasms 1Lung Metastases 1Carcinoma, Renal Cell 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Sunitinib 5Everolimus 5Nivolumab 4pazopanib 3cabozantinib 2aldesleukin 2palbociclib 1olaparib 1lenvatinib 1Zoledronic Acid 1Tobacco Use Cessation Devices 1Standard of Care 1Specimen Handling 1Sorafenib 1Single Person 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Nutrition Therapy 1Midazolam 1Ipilimumab 1Interferons 1Immune Checkpoint Inhibitors 1High-Energy Shock Waves 1Gene Expression Profiling 1Gemcitabine 1Erlotinib Hydrochloride 1Early Intervention, Educational 1Counseling 1Caffeine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Renal Cell × Zoledronic Acid × Clear all
NCT00172003 2016-11-18

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Novartis

Phase 4 Completed
50 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡